Walgreens Boots: EPS down 41% in Q4

(CercleFinance.com) - For Q4 2023-24, Walgreens Boots Alliance reported adjusted EPS that is down 40.
8% at constant exchange rates, to $0.39, on revenue growth that rose 6% to $37.5bn, supported by all its segments. NB: pmt +4.5%.

Our Q4 and FY financial results reflect our disciplined execution of cost management, working capital initiatives and reduced capex, management said.

The drugstore chain's FY adjusted EPS fell 27.9% to $2.88, the middle of its target range provided three months ago ($2.80 to $2.95). The group expects FY 2024-25 between $1.40 and $1.80.

It has also announced a footprint optimization program targeting some 1,200 closures over the next three years, including around 500 in 2024-25, which will have an immediate accretive effect on adjusted EPS and free cash flow.


Copyright (c) 2024 CercleFinance.com. All rights reserved.